as on November 7, 2025 at 9:36 pm IST
Day's Low
Day's High
0.16%
Downside
0.03%
Upside
52 Week's Low
52 Week's High
69.17%
Downside
1.05%
Upside
Check Avidity Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$10.3B
EPS (TTM)
-4.2502
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-18.55
Industry PE ratio
8.355964912280701
PEG Ratio
0EBITDA
-518.7M
Revenue (TTM)
10.7M
Profit Margin
0.00%
Return On Equity TTM
-37.76%
Track how Avidity Biosciences Inc P/E has moved over time to understand its valuation trends.
Avidity Biosciences Inc in the last 5 years
Lowest (-15.07x)
September 30, 2024
Today (-18.55x)
November 7, 2025
Industry (8.36x)
November 7, 2025
Highest (-2.31x)
December 31, 2023
Today’s Price to Earnings Ratio: -18.55x
Compare market cap, revenue, PE, and other key metrics of Avidity Biosciences Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $10.3B | NA | -18.55 | 0.00% | |
| BUY | $39.6B | 470.1% | -16.34 | -264.83% | |
| BUY | $57.4B | 236.95% | 1448.53 | 1.36% | |
| BUY | $105.8B | 88.96% | 29.32 | 31.35% | |
| BUY | $67.7B | 11.91% | 15.43 | 32.13% |
The Avidity Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Avidity Biosciences Inc investment value today
Current value as on today
₹1,51,981
Returns
₹51,981
(+51.98%)
Returns from Avidity Biosciences Inc Stock
₹46,874 (+46.87%)
Dollar Returns*
₹5,107 (+5.11%)
Based on 12 analysts
91.67%
Buy
8.33%
Hold
0.00%
Sell
Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Avidity Biosciences Inc. Average target price of $73.67
Get share price movements and forecasts by analysts on Avidity Biosciences Inc.
What analysts predicted
5.28%UPSIDE
Target Price
$73.67
Current Price
$69.78
Analyzed by
12 Analysts
Target
$73.67
Avidity Biosciences Inc target price $73.67, a slight upside of 5.28% compared to current price of $69.78. According to 12 analysts rating.
Investment in Avidity Biosciences Inc Shares on INDmoney has dropped by -52.58% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Avidity Biosciences Inc Stock has increased by 101% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:101% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 28 October
Tue, 04:28 PM
-Novartis agrees to acquire Avidity Biosciences for $12 billion, enhancing its neuroscience and rare disease portfolio.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 1.57M → 3.84M (in $), with an average increase of 59.1% per quarter
Price Rise
![]()
In the last 1 month, RNA stock has moved up by 48.6%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 921.9% return, outperforming this stock by 495.3%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 159.0% return, outperforming this stock by 112.1%
Profit Down
![]()
Netprofit is down for the last 9 quarters, -47.02M → -157.31M (in $), with an average decrease of 16.7% per quarter
| Organisation | Avidity Biosciences Inc |
| Headquarters | 10578 Science Center Drive, San Diego, CA, United States, 92121 |
| Industry | Health Technology |
| CEO | Ms. Sarah Boyce |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Eric B. Mosbrooker | Chief Commercial Officer |
Ms. Kathleen P. Gallagher | Chief Program Officer |
Ms. Katja Lange | Senior VP & Chief Business Officer |
Dr. Troy Edward Wilson J.D., Ph.D. | Co-Founder & Independent Chairman |
Mr. John B. Moriarty Jr., ESQ., J.D. | Chief Legal Officer & Corporate Secretary |
Mr. Charles Calderaro III | Chief Technical Officer |
Dr. Steven George Hughes M.B.A., M.D. | Chief Medical Officer |
Ms. Sarah Boyce | President, CEO & Director |
Dr. W. Michael F. Flanagan Ph.D. | Chief Scientific Officer |
Ms. Teresa McCarthy | Chief Human Resources Officer |
Avidity Biosciences Inc share price today is $69.78 as on . Avidity Biosciences Inc share today touched a day high of $69.8 and a low of $69.67.
Avidity Biosciences Inc share touched a 52 week high of $70.51 on and a 52 week low of $21.51 on . Avidity Biosciences Inc stock price today i.e. is trending at $69.78,which is 1.04% down from its 52 week high and 224.41% up from its 52 week low.
Avidity Biosciences Inc market capitalisation is $0.01T as on .
Indian investors can start investing in Avidity Biosciences Inc (RNA) shares with as little as ₹88.626 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.26 in Avidity Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Avidity Biosciences Inc share’s latest price of $69.78 as on November 7, 2025 at 9:36 pm IST, you will get 0.1433 shares of Avidity Biosciences Inc. Learn more about
fractional shares .